CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Over the last 12 months, insiders at CEL-SCI Corporation have bought $80,620 and sold $0 worth of CEL-SCI Corporation stock.
On average, over the past 5 years, insiders at CEL-SCI Corporation have bought $170,747 and sold $269,917 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Watson Robert Eugene (director) — $55,600. KERSTEN GEERT R (Chief Executive Officer) — $41,700. PRICHEP PATRICIA B (Senior Vice President) — $11,120.
The last purchase of 30,000 shares for transaction amount of $41,700 was made by KERSTEN GEERT R (Chief Executive Officer) on 2024‑05‑08.
2024-05-08 | Chief Executive Officer | 30,000 0.0556% | $1.39 | $41,700 | -22.30% | |||
2024-05-08 | Senior Vice President | 8,000 0.0148% | $1.39 | $11,120 | -22.30% | |||
2024-05-08 | director | 20,000 0.0371% | $1.39 | $27,800 | -22.30% | |||
2021-10-19 | Sale | Chief Scientific Officer | 15,000 0.0345% | $11.25 | $168,750 | -63.02% | ||
2021-07-06 | Chief Executive Officer | 25,000 0.0615% | $8.00 | $200,000 | -9.69% | |||
2021-07-06 | director | 1,250 0.0031% | $8.00 | $10,000 | -9.69% | |||
2021-07-06 | director | 1,250 0.0031% | $8.00 | $10,000 | -9.69% | |||
2021-06-28 | director | 3,000 0.0068% | $12.66 | $37,971 | -44.12% | |||
2021-04-22 | Sale | Senior Vice President | 10,000 0.0244% | $24.38 | $243,793 | -62.09% | ||
2020-12-11 | director | 100 0.0003% | $14.24 | $1,424 | -8.02% | |||
2020-11-18 | director | 800 0.0021% | $11.77 | $9,416 | +16.45% | |||
2020-11-18 | director | 800 0.0021% | $11.77 | $9,416 | +16.45% | |||
2020-11-17 | director | 800 0.0021% | $11.68 | $9,343 | +16.15% | |||
2020-11-13 | Sale | Senior Vice President | 10,000 0.026% | $12.73 | $127,290 | +6.47% | ||
2020-11-04 | director | 3,000 0.0076% | $11.35 | $34,060 | +16.45% | |||
2020-02-26 | Chief Executive Officer | 4,617 0.0128% | $10.83 | $50,002 | +23.45% | |||
2020-02-26 | Senior Vice President | 3,694 0.0051% | $5.42 | $20,003 | +23.45% | |||
2020-02-26 | Senior Vice President | 923 0.0026% | $10.83 | $9,996 | +23.45% | |||
2020-02-26 | director | 923 0.0026% | $10.83 | $9,996 | +23.45% | |||
2020-02-26 | director | 923 0.0026% | $10.83 | $9,996 | +23.45% |
KERSTEN GEERT R | Chief Executive Officer | 1195309 1.613% | $0.41 | 30 | 0 | +9.11% |
PRICHEP PATRICIA B | Senior Vice President | 232326 0.3135% | $0.41 | 7 | 0 | +0.31% |
Watson Robert Eugene | director | 24431 0.033% | $0.41 | 4 | 0 | +10.07% |
KINSOLVING C RICHARD | director | 302247 0.4079% | $0.41 | 0 | 4 | |
DE CLARA MAXIMILIAN | President | 251234 0.339% | $0.41 | 0 | 67 | |
ZIMMERMAN DANIEL H | Senior Vice President | 114387 0.1544% | $0.41 | 5 | 3 | +23.45% |
TALOR EYAL | Chief Scientific Officer | 104899 0.1416% | $0.41 | 4 | 16 | |
CIPRIANO JOHN | Senior Vice President | 63108 0.0852% | $0.41 | 3 | 5 | |
YOUNG PETER R | director | 28914 0.039% | $0.41 | 13 | 2 | +23.96% |
BAILLAVOINE BRUNO JEAN-MARIE | director | 5973 0.0081% | $0.41 | 3 | 0 | +10.07% |
ESTERHAZY ALEXANDER G | director | 0 0% | $0.41 | 0 | 8 |
The Vanguard Group | $4.19M | 4.05 | 2.19M | +5.47% | +$217,172.75 | <0.0001 | |
Cvi Holdings Llc | $1.68M | 1.62 | 878,767 | New | +$1.68M | 1.75 | |
BlackRock | $1.46M | 1.41 | 763,443 | +1.14% | +$16,498.58 | <0.0001 | |
Susquehanna International Group | $1.28M | 1.24 | 668,989 | +72.28% | +$536,091.16 | <0.01 | |
Geode Capital Management | $887,256.00 | 0.86 | 464,409 | -2.92% | -$26,726.06 | <0.0001 | |
Advisor Group Holdings Inc | $588,616.00 | 0.57 | 308,178 | -15.45% | -$107,562.83 | <0.01 | |
State Street | $370,553.00 | 0.36 | 194,007 | 0% | +$0 | <0.0001 | |
D. E. Shaw & Co. | $360,121.00 | 0.35 | 188,545 | +78.59% | +$158,474.63 | <0.0001 | |
Two Sigma | $304,645.00 | 0.29 | 159,500 | +58.63% | +$112,602.14 | <0.0001 | |
Bridgeway Capital Management | $290,129.00 | 0.28 | 151,900 | +1.33% | +$3,820.00 | <0.01 | |
Renaissance Technologies | $256,000.00 | 0.25 | 133,800 | +237.03% | +$180,041.85 | <0.0001 | |
Northern Trust | $226,110.00 | 0.22 | 118,382 | +41.16% | +$65,929.49 | <0.0001 | |
Lincoln National Corporation | $220,118.00 | 0.21 | 115,245 | +32.4% | +$53,862.01 | <0.01 | |
Cutter Co Brokerage Inc | $160,079.00 | 0.16 | 83,811 | -1.06% | -$1,719.00 | 0.03 | |
Millennium Management LLC | $133,085.00 | 0.13 | 69,678 | New | +$133,085.00 | <0.0001 | |
Jane Street Capital | $112,458.00 | 0.11 | 58,879 | -2.24% | -$2,574.66 | <0.0001 | |
Thoroughbred Financial Inc | $108,000.00 | 0.11 | 56,760 | -55.22% | -$133,194.29 | 0.01 | |
Black Diamond Financial, LLC | $144,160.00 | 0.1 | 53,000 | 0% | +$0 | 0.04 | |
UBS | $99,929.00 | 0.1 | 52,319 | +134.48% | +$57,311.29 | <0.0001 | |
Cantor Fitzgerald L P | $91,683.00 | 0.09 | 50,100 | -58.59% | -$129,747.00 | <0.01 | |
Group One Trading | $78,203.00 | 0.08 | 40,944 | -42.09% | -$56,841.57 | <0.01 | |
Citadel Advisors LLC | $67,889.00 | 0.07 | 35,544 | -23.59% | -$20,956.51 | <0.0001 | |
D.A. Davidson Companies | $61,693.00 | 0.06 | 32,300 | -88.9% | -$493,979.48 | <0.01 | |
Simplex Trading Llc | $59,000.00 | 0.06 | 31,364 | +10.08% | +$5,404.51 | <0.01 | |
Bank of America | $55,686.00 | 0.05 | 29,155 | -4.63% | -$2,704.56 | <0.0001 | |
T. Rowe Price | $52,000.00 | 0.05 | 26,800 | 0% | +$0 | <0.0001 | |
Creative Planning | $50,615.00 | 0.05 | 26,500 | 0% | +$0 | <0.0001 | |
Gsa Capital Partners Llp | $49,000.00 | 0.05 | 25,561 | New | +$49,000.00 | <0.01 | |
Vontobel Holding Ltd | $47,750.00 | 0.05 | 25,000 | 0% | +$0 | <0.0001 | |
LINSCO PRIVATE LEDGER CORP | $43,565.00 | 0.04 | 22,809 | 0% | +$0 | <0.0001 | |
Stifel | $38,200.00 | 0.04 | 20,000 | New | +$38,200.00 | <0.0001 | |
Sheets Smith Wealth Management, Inc. | $38,200.00 | 0.04 | 20,000 | 0% | +$0 | <0.01 | |
Man Group Plc | $37,602.00 | 0.04 | 19,687 | -54.13% | -$44,371.01 | <0.0001 | |
Raymond James Associates | $36,057.00 | 0.04 | 18,878 | 0% | +$0 | <0.0001 | |
Wells Fargo | $35,622.00 | 0.03 | 18,650 | +6.01% | +$2,020.81 | <0.0001 | |
Morgan Stanley | $34,608.00 | 0.03 | 18,119 | -58.25% | -$48,283.88 | <0.0001 | |
Virtu Financial Llc | $34,000.00 | 0.03 | 17,781 | -70.41% | -$80,914.68 | <0.01 | |
Citigroup | $32,663.00 | 0.03 | 17,101 | -88.7% | -$256,380.01 | <0.0001 | |
Charles Schwab | $31,479.00 | 0.03 | 16,481 | 0% | +$0 | <0.0001 | |
Dimensional Fund Advisors | $31,484.00 | 0.03 | 16,484 | -33.34% | -$15,749.64 | <0.0001 | |
Xtx Topco Ltd | $31,173.00 | 0.03 | 16,321 | New | +$31,173.00 | <0.01 | |
Chilton Capital Management LLC | $31,137.00 | 0.03 | 16,302 | +297.42% | +$23,302.13 | <0.01 | |
Ameriprise Financial | $29,643.00 | 0.03 | 15,520 | 0% | +$0 | <0.0001 | |
Nations Financial Group Inc Ia Adv | $28,650.00 | 0.03 | 15,000 | 0% | +$0 | <0.01 | |
Benedetti Gucer Inc | $27,000.00 | 0.03 | 14,320 | -14.35% | -$4,525.14 | 0.02 | |
Toroso Investments Llc | $26,532.00 | 0.03 | 13,891 | New | +$26,532.00 | <0.0001 | |
Cresset Asset Management Llc | $23,638.00 | 0.02 | 12,376 | 0% | +$0 | <0.0001 | |
TWO SIGMA SECURITIES LLC | $22,099.00 | 0.02 | 11,570 | New | +$22,099.00 | <0.0001 | |
Squarepoint Ops LLC | $21,612.00 | 0.02 | 11,315 | New | +$21,612.00 | <0.0001 | |
Qube Research & Technologies | $21,134.00 | 0.02 | 11,065 | +8.09% | +$1,581.47 | <0.0001 |